Bryn Mawr Trust CO Moon Lake Immunotherapeutics Put Options Transaction History
Bryn Mawr Trust CO
- $5.88 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MLTX
# of Institutions
156Shares Held
53.2MCall Options Held
799KPut Options Held
661K-
Bvf Inc San Francisco, CA19.8MShares$199 Million36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$85.8 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$41.9 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$26.4 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$16.9 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $373M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...